Naoya Sugimoto

3PUBLICATIONS

29CO-AUTHORS

Human impacts of climate change and human adaptationAllergy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 01, 2026

Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study).

|Aug 13, 2021

Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma.

Konomi Kobayashi, Hiroyuki Nagase, Naoya Sugimoto

|Dec 22, 2018

Anti-interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis.

Fuminori Tomyo, Naoya Sugimoto, Masashi Kawamoto

Pageof 1

Frequent Collaborators

2 joint publications

Hiroyuki Nagase

2 joint publications

Koichi Fukunaga

1 joint publications

Konomi Kobayashi

1 joint publications

Akihiko Tanaka

1 joint publications

Ryo Atsuta

1 joint publications

Masayuki Hojo

1 joint publications

Yasuhiro Gon

1 joint publications

Tatsuro Suzuki

1 joint publications

Yoshihiro Kanemitsu

1 joint publications

Katsunori Masaki

Frequent Collaborators

2 joint publications

Hiroyuki Nagase

2 joint publications

Koichi Fukunaga

1 joint publications

Konomi Kobayashi

1 joint publications

Akihiko Tanaka